implantable cardioverter defibrillator


Also found in: Acronyms.

implantable cardioverter defibrillator

A defibrillator designed to treat a cardiac tachyarrhythmia directly. If a patient has a ventricular defibrillator and the device senses a ventricular rate that exceeds the programmed cut-off rate of the defibrillator, the device performs cardioversion/defibrillation. Alternatively, the device, if so programmed, may attempt to pace rapidly for a number of pulses, usually around 10, to attempt pace-termination of a ventricular tachycardia.
References in periodicals archive ?
9 - Set for implantable cardioverter defibrillator jednojamowego of enlarged; hv pulse configuration and delivered defibrillation energy =36 J;
SAN DIEGO--Cutting-edge implantable cardioverter defibrillators improve patient quality of life, functional Capacity, and exercise tolerance, according to a study presented at the annual meeting of the North American Society of Pacing and Electrophysiology
The report, Global Implantable Cardioverter Defibrillator (ICD) Market 2010-2014 is based on an extensive research from inputs by industry experts, vendors and end-users.
The report by TechNavio Insights forecasts the size of the global implantable cardioverter defibrillator (ICD) over the period 2008-2012.
10 - Set the implantable cardioverter defibrillator dwujamowego of telemonitoringiem of defibrillation energy 35 J.
1 Long-term outcome of patients who receive implantable cardioverter defibrillators for stable ventricular tachycardia.
In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets/applications/technologies: implantable pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, and CRM leads in regions such as China, Hong Kong, South Korea, and Malaysia.
The study thoroughly examines the following segments of the market: pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy devices, and cardiac ablation systems.
Study Will Enroll 450 Patients in Europe and North America with the Objective of Demonstrating Superiority of Dual Chamber Implantable Cardioverter Defibrillators (ICDs) In Patients with Life-Threatening Tachyarrhythmias

Full browser ?